Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
39.65B | 42.76B | 37.06B | 33.14B | 30.26B | 31.56B | Gross Profit |
8.84B | 9.23B | 7.83B | 6.56B | 5.95B | 5.57B | EBIT |
4.51B | 4.82B | 3.58B | 2.67B | 2.33B | 2.29B | EBITDA |
4.62B | 5.20B | 3.79B | 2.88B | 2.65B | 2.40B | Net Income Common Stockholders |
3.09B | 3.38B | 2.42B | 1.83B | 1.58B | 1.42B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
9.39B | 2.17B | 2.20B | 2.63B | 1.90B | 2.07B | Total Assets |
26.75B | 30.20B | 26.83B | 23.02B | 21.93B | 20.05B | Total Debt |
0.00 | 14.00M | 22.00M | 30.00M | 41.00M | 5.00M | Net Debt |
-1.47B | -2.16B | -2.17B | -1.74B | -1.43B | -1.76B | Total Liabilities |
7.20B | 9.50B | 8.67B | 7.19B | 7.55B | 7.01B | Stockholders Equity |
18.13B | 19.17B | 16.75B | 14.57B | 13.22B | 11.97B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.86B | 3.42B | -771.00M | 2.30B | 717.00M | Operating Cash Flow |
0.00 | 3.02B | 4.09B | -430.00M | 2.45B | 806.00M | Investing Cash Flow |
0.00 | -2.10B | -2.76B | 1.25B | -2.32B | -1.22B | Financing Cash Flow |
0.00 | -939.00M | -899.00M | -526.00M | -420.00M | -381.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥90.70B | 10.49 | 2.38% | 15.78% | 20.79% | ||
76 Outperform | ¥44.29B | 10.22 | 3.42% | -21.30% | -13.60% | ||
75 Outperform | ¥45.00B | 13.30 | 2.97% | 15.38% | 39.87% | ||
75 Outperform | ¥20.53B | 9.25 | 4.69% | 8.75% | ― | ||
75 Outperform | ¥39.05B | 11.15 | 4.13% | 8.08% | 14.26% | ||
74 Outperform | ¥40.66B | 27.64 | 0.18% | 11.39% | -0.31% | ||
66 Neutral | $4.49B | 12.22 | 5.40% | 3.71% | 4.17% | -11.97% |